METHOD FOR THE INCORPORATION OF FORMALDEHYDE INTO BIOMASS
20230212622 · 2023-07-06
Inventors
Cpc classification
C12N9/1205
CHEMISTRY; METALLURGY
C12N1/32
CHEMISTRY; METALLURGY
C12N9/1029
CHEMISTRY; METALLURGY
C12N15/70
CHEMISTRY; METALLURGY
C12P19/32
CHEMISTRY; METALLURGY
International classification
Abstract
Described is a method for the incorporation of formaldehyde into biomass comprising the following enzymatically catalyzed steps (1) condensation of pyruvate with formaldehyde into 4-hydroxy-2-oxobutanoic acid (HOB); (2) amination of the thus produced 4-hydroxy-2-oxobutanoic acid (HOB) to produce homoserine; (3) conversion of thus produced homoserine to threonine; (4) conversion of the thus produced threonine into glycine and acetaldehyde or acetyl-CoA; (5) condensation of the thus produced glycine with formaldehyde to produce serine; and (6) conversion of the thus produced serine to produce pyruvate, wherein said pyruvate can then be used as a substrate in step (1).
Claims
1. A method comprising the following enzymatically catalyzed steps (1) condensation of pyruvate with formaldehyde into 4-hydroxy-2-oxobutanoic acid (HOB); (2) amination of the thus produced 4-hydroxy-2-oxobutanoic acid (HOB) to produce homoserine; (3) conversion of thus produced homoserine to threonine; (4) conversion of the thus produced threonine into glycine and acetaldehyde or acetyl-CoA; (5) condensation of the thus produced glycine with formaldehyde to produce serine; and (6) conversion of the thus produced serine to produce pyruvate, wherein said pyruvate can then be used as a substrate in step (1).
2. The method of claim 1, wherein the conversion of homoserine to threonine in step (3) takes place by (i) phosphorylation of thus produced homoserine to produce o-phosphohomoserine; and (ii) dephosphorylation of the thus produced o-phosphohomoserine to produce threonine.
3. The method of claim 1 , wherein the conversion of serine into pyruvate in step (6) is achieved by deamination.
4. The method of claims 1,wherein the method comprises at least one of (a) in step (1) the condensation of pyruvate with formaldehyde into 4-hydroxy-2-oxobutanoic acid (HOB) is achieved using an aldolase classified in EC 4.1.2._; (b) in step (2) the amination of the 4-hydroxy-2-oxobutanoic acid (HOB) to produce homoserine is achieved by using an aminotransferase enzyme classified in EC 2.6.1._ or by an amino acid dehydrogenase (EC 1.4.1._); (c) in step (3)the conversion of homoserine to threonine is achieved by (i) phosphorylation of the homoserine to produce o-phosphohomoserine is achieved by using a homoserine kinase (EC 2.7.1.39); and (ii) dephosphorylation of the thus produced o-phosphohomoserine to produce threonine achieved by using a threonine synthase (EC 4.2.3.1); (d) in step (4) the conversion of the threonine into glycine and acetaldehyde is achieved by using a threonine aldolase (selected from the group consisting of EC 4.1.2.5, EC 4.1.2.6, EC 4.1.2.48 and EC 4.1.2.49) and/ or the conversion of the threonine into glycine and acetyl-CoA is achieved by a combination of a threonine dehydrogenase (EC 1.1.1.103) and a 2-amino-3-ketobutyrate CoA ligase (EC 2.3.1.29); (e) in step (5) the condensation of the glycine with formaldehyde to produce serine is achieved by using a threonine aldolase selected from the group consisting of EC 4.1.2.5, EC 4.1.2.6, EC 4.1.2.48 and EC 4.1.2.49; and (f) in step (6) the conversion of the thus produced serine to produce pyruvate is achieved by using a serine deaminase (EC 4.3.1.17) or a threonine deaminase (EC4.3.1.19); or any combination of (a) to f.
5. The method of claims 1, wherein the formaldehyde used for the condensation in step (1) and/or (5) is provided by the oxidation of methanol.
6. The method of claims 1,wherein the formaldehyde in step (1) and/or (5) is provided by (a) converting methanol enzymatically into formaldehyde using a methanol dehydrogenase (EC 1.1.1.244) or a methanol dehydrogenase (cytochrome c) (EC 1.1.2.7); and/or (b) converting methanol enzymatically into formaldehyde using an alcohol oxidase (EC 1.1.3.13).
7. A recombinant microorganism expressing enzymes for catalyzing the following reactions: (1) condensation of pyruvate with formaldehyde into 4-hydroxy-2-oxobutanoic acid (HOB) by an aldolase classified in EC 4.1.2._; (2) amination of the thus produced 4-hydroxy-2-oxobutanoic acid (HOB) to produce homoserine by an aminotransferase enzyme classified in EC 2.6.1._ or by an amino acid dehydrogenase (EC 1.4.1._); (3) phosphorylation of thus produced homoserine to produce o-phosphohomoserine by a homoserine kinase (EC 2.7.1.39); (4) dephosphorylation of the thus produced o-phosphohomoserine to produce threonine by a threonine synthase (EC 4.2.3.1); (5) conversion of the thus produced threonine into glycine by a threonine aldolase (selected from the group consisting of EC 4.1.2.5, EC 4.1.2.6, EC 4.1.2.48 and EC 4.1.2.49) or by a combination of a threonine dehydrogenase (EC 1.1.1.103) and a 2-amino-3-ketybutyrate CoA ligase (EC 2.3.1.29); (6) condensation of the thus produced glycine with formaldehyde to produce serine by a threonine aldolase (selected from the group consisting of EC 4.1.2.5, EC 4.1.2.6, EC 4.1.2.48 and EC 4.1.2.49); and (7) deamination of the thus produced serine to produce pyruvate by a serine deaminase (EC 4.3.1.17 or a threonine deaminase (EC 4.3.1.19)), wherein said pyruvate can then be used as a substrate in step (1), wherein said microorganism contains at least one heterologous nucleic acid molecule encoding the aldolase catalyzing step (1) and overexpresses the enzyme catalyzing step (6), i.e. the condensation of glycine with formaldehyde to form serine.
8. The microorganism of claim 7 which furthermore overexpresses at least one of the enzymes catalyzing step (3), step (4) or step (5).
9. The microorganism of claim 7 which is capable of converting methanol into formaldehyde.
10. The microorganism of claim 9, wherein said microorganism (a) converts methanol enzymatically into formaldehyde by a methanol dehydrogenase (EC 1.1.1.244) or a methanol dehydrogenase (cytochrome c) (EC 1.1.2.7); and/or (b) converts methanol enzymatically into formaldehyde by an alcohol oxidase (EC 1.1.3.13).
11. The microorganism of claim 7, wherein said microorganism is deficient in an enzyme activity converting pyryvate into aspartate semialdehyde.
12. The microorganism of claim 7, wherein said microorganism is deficient in the enzyme activity of 3-phosphoglycerate dehydrogenase (EC 1.1.1.95).
13. The microorganism of claim 7, wherein said microorganism is deficient in the enzyme activity of serine hydroxymethyltransferase (EC 2.1.2.1) and/or in the glycine cleavage system (gcvTHP).
14. The microorganism of claim 7 which is E.coli.
Description
[0229]
[0230] Condensation of pyruvate with formaldehyde into 4-hydroxy-2-oxobutanoic acid (HOB) via an aldolase; (2) amination of the thus produced 4-hydroxy-2-oxobutanoic acid (HOB) to produce homoserine; (3) phosphorylation of thus produced homoserine to produce o-phosphohomoserine; (4) dephosphorylation of the thus produced o-phosphohomoserine to produce threonine; (5) conversion of the thus produced threonine into glycine and acetaldehyde; (6) condensation of the thus produced glycine with formaldehyde to produce serine; and (7) conversion of the thus produced serine to produce pyruvate. Reactions based on promiscuous enzyme activities are shown in color.
[0231]
[0232]
[0233]
[0234]
[0235]
[0236]
[0237]
[0238] In this specification, a number of documents including patent applications are cited. The disclosure of these documents, while not considered relevant for the patentability of this invention, is herewith incorporated by reference in its entirety. More specifically, all referenced documents are incorporated by reference to the same extent as if each individual document was specifically and individually indicated to be incorporated by reference.
[0239] The invention will now be described by reference to the following examples which are merely illustrative and are not to be construed as a limitation of the scope of the present invention.
EXAMPLES
[0240] To confirm the in vivo feasibility of the homoserine cycle, several E.coli gene deletion strains were constructed whose growth is coupled to the activity of different pathway segments. Using this approach it could be demonstrated that all required promiscuous enzymes are active enough to enable growth of the auxotrophic strains.
Methods
[0241] Strains and genomic manipulation. Strains used in this study are listed in Table 1.
TABLE-US-00001 LIST OF E.COLI STRAINS STRAIN GENOTYPE REFERENCE OR SOURCE MG1655 K-12 F.sup.- Λ.sup.- ILVG.sup.-RFB-50 RPH-1 LAB COLLECTION SIJ488 MG1655 TN7::PARA-EXO-BETA-GAM; PRHA-FLP; XYLSPM-ISCEI F.sup.- ENDAl GLNV44 THI-1 RECAl RELAl GYRA96 1 DH5A DEOR NUPG PURB20 ϕ80DLACZΔM15 Δ(LACZYA-ARGF)U169, HSDR17(R.sub.K.sup.-M.sub.K.sup.+), Λ.sup.- LAB COLLECTION SIJ488 ΔFRMRAB ΔSERA ΔGLYA THIS STUDY SIJ488 ΔFRMRAB ΔSERA ΔGCVTHP THIS STUDY SIJ488 ΔFRMRAB ΔSERA ΔGLYA ΔKBL-TDH THIS STUDY SIJ488 ΔFRMRAB ΔSERA ΔGCVTHP ΔKBL-TDH THIS STUDY SIJ488 ΔFRMRAB ΔASD THIS STUDY PTHRBC_D SIJ488 ΔP.sub.THRLABC::CAP-P.sub.PGI-20-THRBC THIS STUDY PALAC_D SIJ488 ΔP.sub.ALAC::CAP-P.sub.PGI-20-ALAC* THIS STUDY PASPC_D SIJ488 ΔP.sub.ASPC::CAP-P.sub.PGI-20-ASPC THIS STUDY SIJ488 4FRMRAB ΔASD ΔP.sub.THRLABC::P.sub.PGI-20-THRBC THIS STUDY SIJ488 4FRMRAB ΔASD ΔP.sub.ALAC::P.sub.PCI-20-ALAC* THIS STUDY SIJ488 4FRMRAB ΔASD ΔP.sub.ASPC::P.sub.PGi-20-ASPC THIS STUDY SIJ488 4FRMRAB ΔASD ΔP.sub.THRLABC::P.sub.PGI-20-THRBC THIS STUDY ΔP.sub.ALAC::P.sub.PGI-20-ALAC* SIJ488 4FRMRAB ΔASD ΔP.sub.THRLABC::P.sub.PGI-20-THRBC THIS STUDY ΔP.sub.ASPC::P.sub.PGI-20-ASPC .sup.1 Jensen et al. (Sci. Rep. 5 (2015), 17874)
[0242] An E.coli MG1655 derived strain SIJ488 (Jensen et al., Scientific Reports 5 (2015), 17874) was used as the parental strain for genomic modifications. Iterative rounds of λ-Red recombineering (Jensen et al., loc. cit.) or P1 phage transduction (Thomason et al., Curr. Protoc. Mol. Biol. Chapter 1, Unit 1 17 (2007)) were used for gene deletions. For the recombineering, selectable resistance cassettes were generated via PCR — primers 50 bp homologous arms as in Baba et al. (Mol. Syst. Biol. 2 (2006), 2006-2008) — using the FRT-PGK-gb2-neo-FRT (Km) cassette (Gene Bridges, Germany) for kanamycin resistance (Km) and the pKD3 plasmid (GenBank: AY048742; Datsenko and Wanner, Proc. Natl. Acad. Sci. USA 97 (2000), 6640-6645) as template for chloramphenicol resistance cassettes (CAP). The procedures of the deletion, verification and antibiotic cassette removal are detailed in Wenk et al. (Methods Enzymol. 608 (2018), 329-367).
[0243] A similar strategy was applied to exchange the genomic promoter of target genes. A constitutive strong promoter pgi-20 (Braatsch et al., Biotechniques 45 (2008), 335-337) and a ribosome binding site “C” (AAGTTAAGAGGCAAGA (SEQ ID NO: 44); Zelcbuch et al., Nucleic Acids Res. 41 (2013), e98.) were constructed downstream of the CAP cassette using primers listed shown in Table 2.
TABLE-US-00002 LIST OF OLIGO PRIMERS USED IN THIS STUDY PRIMER SEQUENCE (5′.fwdarw.3′) RHMA_F ATGCATCATCACCATCACCACAACGCATTATTAAGCAATCCC (SEQ ID NO:6) RHMA_R GCGCTAGCTCAATAACTACCTTTTATGC (SEQ ID NO:7) YAGE_F ATGCATCATCACCATCACCACACCGCAGTCCGCGTTGTTC (SEQ ID NO:8) YAGE_R GCTAGCATTAGCAAAGCTTGAGCTGTTG (SEQ ID NO:9) YJHH_F ATGCATCATCACCATCACCACAAAAAAATTCAGCGGCATTATTCC (SEQ ID NO:10) YJHH_R GCTAGCATTAGACTGGTAAAATGCCCT (SEQ ID NO:11) YJHH_C TAATAAAGGGGTTGACGGGCTG (SEQ ID NO:12) YJHH_D CAGCCCGTCAACCCCTTTATTA (SEQ ID NO:13) YJHH_A GTAACCATTGTTGACGGGCGAG (SEQ ID NO:14) YJHH_B CTCGCCCGTCAACAATGGTTAC (SEQ ID NO:15) DGOA_F ATGCATCATCACCATCACCACACAGTGGCAAACTAAACTCC (SEQ ID NO:16) DGOA_R GCTAGCATCATTGCACTGCCTCTCG (SEQ ID NO:17) DGOA_B TCCCGCTGAACTCCCCACAATG (SEQ ID NO:18) DGOA_C CATTGTGGGGAGTTCAGCGGGA (SEQ ID NO:19) EDA_A GAATGCATCATCACCATCACCACAAAAACTGGAAAACAAGTGCAGAATCAATCCTGACCAC (SEQ ID NO:20) EDA_B GAACGGACCCGCAATCGCTTGCAGGGCTTTCAC (SEQ ID NO:21) EDA_C GTGAAAGCCCTGCAAGCGATTGCGGGTCCGTTC (SEQ ID NO:22) EDA_D CGCTAGCTCTAGATTACAGCTTAGCGCCTTCTACAGCTTCACG (SEQ ID NO:23) MHPE_F ATGCATCATCACCATCACCACAAACGGTAAAAAACTTTATATCTCGGACG (SEQ ID NO:24) MHPE_R GCTAGCATTATTTGTTGTTGCGCAGATC (SEQ ID NO:25) LTAE_F ATGCATCATCACCATCACCACATTGATTTACGCAGTGATACCGTTACCCGACC (SEQ ID NO:26) LTAE_B GCTGCGTAGTCTTGCAGAGCATTAAC (SEQ ID NO:27) LTAE_C GTTAATGCTCTGCAAGACTACGCAGC (SEQ ID NO:28) LTAE_R CTCTTACGTGCCCGATCAACGCTAGCTTAACGCGCCAGGAATGCACGCCAG (SEQ ID NO:29) GARL_F GTTAAGAGGCAAGAATGCATAATAACGATGTTTTCCCGAA (SEQ ID NO:30) GARL_R CCGCGCTAGCTCTAGATTATTTTTTAAAGGTATCAGCCAGT (SEQ ID NO:31) ALAC_F ATGCATCATCACCATCACCACGCTGACACTCGCCCTGAA (SEQ ID NO:32) ALAC_C GCGCGGTGATTCCAGGGGCGCAGGTA (SEQ ID NO:33) ALAC_B TACCTGCGCCCCTGGAATCACCGCGC (SEQ ID NO:34) ALAC_E GCTATCACGATGACGGCACCTTTACG (SEQ ID NO:35) ALAC_D CGTAAAGGTGCCGTCATCGTGATAGC (SEQ ID NO:36) ALAC_R GCTAGCTTATTCCGCGTTTTCGTGAA (SEQ ID NO:37) PALAC_R AGTAAACCGTCGGCACGGAACATC (SEQ ID NO:38) PALAC_F CTCTATGATAGGTAACCTGAAGGCTGATGACCAGCAGGCCGTTTTTGAGGAATTAACCCTCACT AAAGGGCG (SEQ ID NO:39) PTHRBC_ R AACCCGACGCTCATATTGGCACTGGAAGCCGGGGCATAAACTTTAACCATTCTTGCCTCTTAAC TTTAAAG (SEQ ID NO:40) PTHRBC_ F CAATGTTGCACCGTTTGCTGCATGATATTGAAAAAAATATCACCAAATAAAATTAACCCTCACT AAAGGGCG (SEQ ID NO:41) PASPC_F GGTCCTGTTTTTTTTATACCTTCCAGAGCAATCTCACGTCTTGCAAAAACAATTAACCCTCACT AAAGGGCG (SEQ ID NO:42) PASPC_R GCCAGGCCCAGAATCGGGTCGGCAGGAGCGGCGGTAATGTTCTCAAACATTCTTGCCTCTTAAC TTTAAAG (SEQ ID NO:43)
[0244] The synthetic promoter was first introduced to the SIJ488 strain by the recombineering method; P1 transduction was then used to transfer the synthetic promoter into the selection strains. thrB (encoding homoserine kinase, HSK) and thrC (encoding threonine synthase, TS) are on the same operon with thrL and thrA. Since thrL encodes a regulatory peptide and thrA is redundant in the Δasd selection strains, thrLA was deleted during the promoter exchange of thrBC. The point mutations A142P Y275D (Bouzon et al., ACS Synthetic Biology 6 (2017), 1520-1533) were introduced along with the promoter exchange of alaC (In this case, the recombineering cassette has the mutated gene downstream the CAP cassette and synthetic promoter). Promoter exchanges were confirmed by sequencing the promoter regions.
[0245] Plasmids construction. All cloning procedures were carried out in E.coli DH5α strain. E.coli native genes ItaE, rhmA, garL, yagE, yjhH, eda, dgoA and mhpE, were cloned from E.coli MG1655 genome with the primers shown in Table 2, above.
[0246] NAD-dependent methanol dehydrogenase (CgAdhA) was taken from Corynebacteriumglutamicum R after codon optimization (He et al., ACS Synthetic Biology 7 (2018), 1601-1611). Genes were inserted into a pNivC vector downstream of a ribosome binding site “C” (AAGTTAAGAGGCAAGA (SEQ ID NO: 44); Zelcbuch et al., Nucleic Acids Res. 41 (2013), e98.). The genes were assembled into one operon using BioBrick enzymes: Bcul, Sall, Nhel and Xhol (FastDigest, Thermo Scientific; Zelcbuch et al., Nucleic Acids Res. 41 (2013), e98.). Using EcoRI and Pstl, the synthetic operon was then inserted into an overexpression pZASS vector (Wenk et al., Methods Enzymol. 608 (2018), 329-367) under a constitutive strong promoter pgi-20 (Braatsch et al., Biotechniques 45 (2008), 335-337). The final plasmids are listed in the Table 3.
TABLE-US-00003 SUPPLEMENTARY TABLE S4 THE LIST OF OVEREXPRESSION PLASMIDS PLASMID GENES PZASS P15A ORI; STREP.sup.R; P.sub.PGI-20 PZASS-MDH PZASS::CGADHA PZASS-LTAE-MDH PZASS::LTAE, CGADHA PZASS-LTAE PZASS::LTAE PZASS-MDH-RHMA PZASS::CGADHA, RHMA PZASS-RHMA PZASS::RHMA PZASS-MDH-GARL PZASS::CGADHA, GARL PZASS-GARL PZASS::GARL PZASS-MDH-YAGE PZASS::CGADHA, YAGE PZASS-YAGE PZASS::YAGE PZASS-MDH-YJHH PZASS::CGADHA, YJHH PZASS-YJHH PZASS::YJHH PZASS-MDH-EDA PZASS::CGADHA, EDA PZASS-EDA PZASS::EDA PZASS-MDH-DGOA PZASS::CGADHA, DGOA PZASS-DGOA PZASS::DGOA PZASS-MDH-MHPE PZASS::CGADHA, MHPE PZASS-MHPE PZASS::MHPE
[0247] Growth media. LB medium (0.5% yeast extract, 1% tryptone, 1% NaCl) was used for strain engineering and recombinant plasmids cloning. Antibiotics were used at the following concentrations: kanamycin, 50 .Math.g/mL; ampicillin, 100 .Math.g/mL; streptomycin, 100 .Math.g/mL; chloramphenicol, 30 .Math.g/mL. Growth experiments were performed in M9 minimal media (47.8 mM Na.sub.2HPO.sub.4, 22 mM KH.sub.2PO.sub.4, 8.6 mM NaCl, 18.7 mM NH.sub.4Cl, 2 mM MgSO.sub.4 and 100 .Math.M CaCl.sub.2), supplemented with trace elements (134 .Math.M EDTA, 31 .Math.M FeCl.sub.3, 6.2 .Math.M ZnCl.sub.2, 0.76 .Math.M CuCl.sub.2, 0.42 .Math.M CoCl.sub.2, 1.62 .Math.M H.sub.3BO.sub.3, 0.081 .Math.M MnCl.sub.2). Additional 50 .Math.M MnCl.sub.2 was added for all experiments since it improves in vivo activity of LtaE (
[0248] Growth experiments. Strains were precultured in 4 mL M9 medium with proper carbon sources and streptomycin. The precultures were harvested and washed three times in M9 medium, then inoculated in M9 media with suitable carbon sources, with a starting OD.sub.600 of 0.02. 150 .Math.L of culture were added to each well of 96-well microplates (Nunclon Delta Surface, Thermo Scientific). Further 50 .Math.L mineral oil (Sigma-Aldrich) was added to each well to avoid evaporation (while enabling gas diffusion). The 96-well microplates were incubated at 37° C. in microplate reader (BioTek EPOCH 2). The shaking program cycle (controlled by Gen5 v3) had 4 shaking phases, lasting 60 seconds each: linear shaking followed by orbital shaking, both at an amplitude of 3 mm, then linear shaking followed by orbital shaking both at an amplitude of 2 mm. The absorbance (OD.sub.600) in each well was monitored and recorded after every three shaking cycles (~16.5 min). Raw data from the plate reader were calibrated to normal cuvette measured OD.sub.600 values according to OD.sub.cuvette=OD.sub.plate/0.23. Growth parameters were calculated using MATLAB (MathWorks) based on three technical triplicates — the average values were used to generate the growth curves. Checked in MATLAB, in all cases variability between triplicate measurements were less than 5%.
[0249] Stable isotopic labelling. .sup.13C-Methanol, glucose-1-.sup.13C, glucose-2-.sup.13C, glucose-3-.sup.13C were purchased from Sigma-Aldrich. Cells were harvested at the late exponential phase. The equivalent volume of 1 mL of culture at OD.sub.600 of 1 was harvested and washed by centrifugation. Protein biomass was hydrolyzed with 6 M HCl, at 95° C. for 24 h (You et al., Journal of Visualized Experiments 59 (2012)). The samples were completely dried under a stream of air at 95° C. Hydrolyzed amino acids were analyzed with UPLC-ESI-MS as previously described (Giavalisco et al., Plant J. 68 (2011), 364-376). Chromatography was performed with a Waters Acquity UPLC system (Waters), using an HSS T3 C.sub.18 reversed phase column (100 mm × 2.1 mm, 1.8 .Math.m; Waters). 0.1% formic acid in H.sub.2O (A) and 0.1% formic acid in acetonitrile (B) were the mobile phases. The flow rate was 0.4 mL/min and the gradient was: 0 to 1 min — 99% A; 1 to 5 min — linear gradient from 99% A to 82%; 5 to 6 min — linear gradient from 82% A to 1% A; 6 to 8 min — kept at 1% A; 8-8.5 min — linear gradient to 99% A; 8.5-11 min — re-equilibrate. Mass spectra were acquired using an Exactive mass spectrometer (Thermo Scientific) in positive ionization mode, with a scan range of 50.0 to 300.0 m/z. The spectra were recorded during the first 5 min of the LC gradients. Data analysis was performed using Xcalibur (Thermo Scientific). The identification amino acids was based on retention times and m/z, which were determined by analyzing amino acid standards (Sigma-Aldrich) under the same conditions.
[0250] Molecular phylogenetic analysis. The protein sequences of the aldolases used to catalyze the HAL reaction were obtained from UniProt: RhmA/YfaU P76469, GarL P23522, YagE P75682 and YjhH P39359, Eda P0A955, DgoA Q6BF16 and MhpE P51020. MAFFT v7 (Katoh and Standley, Mol. Biol. Evol. 30 (2013), 772-780) was used for multiple sequence alignment with default parameters. The aligned sequences were used by MEGA X (Kumar et al., Mol. Biol. Evol. 35 (2018), 1547-1549) with Maximum Likelihood method to construct a phylogenetic tree. The bootstrap consensus tree was generated with the setting No. of bootstrap replications to 1000.
Example 1
Concept of the Newly Developed “Homoserine Cycle”
[0251] With the aim to provide a metabolic route which is superior to the known native serine cycle, a metabolic pathway was designed which is also referred herein as the “homoserine cycle”. A representative example of the homoserine cycle is shown in
[0252] In the homoserine cycle, glycine is directly condensed with formaldehyde to generate serine. This reaction (item (6) in
Demonstration of the In Vivo Activity of Enzymes Catalyzing the Condensation of Glycine and Formaldehyde into Serine
[0253] As described above, several of the reactions of the newly proposed “homoserine cycle” correspond to the primary activities of their catalyzing enzymes and, thus, are expected to be normally catalyzed in vivo by the respective enzymes and it is also expected that these reactions do not constrain pathway flux. However, three of the reactions of the newly designed “homoserine cycle” (i.e. items (1), (2) and (6) in
[0254] First, the ability of LtaE to catalyze the “SAL reaction” (item (6) in
[0255] It was reasoned that if the SAL reaction indeed supports physiologically relevant flux, both strains should be able to grow when methanol dehydrogenase (MDH) and LtaE are overexpressed and serine is replaced with methanol in the medium. In the ΔserA ΔglyA strain, the SAL reaction would be responsible for the production of serine (
[0256] Upon overexpression of MDH and LtaE growth of both selection strains was observed with glucose as the main carbon source and glycine and methanol as precursors of serine (
[0257] To confirm the activity of the SAL reaction, .sup.13C-labeling experiments were conducted. Both strains were cultivated with .sup.13C-methanol as well as unlabeled glucose and glycine. In the ΔserA ΔglyA ΔfrmRAB strain serine was found to be entirely singly labeled as expected, while the other amino acids were unlabeled (
[0258] Next, it was tested whether it is possible to omit glycine from the medium, such that it will be produced endogenously via LtaE-dependent threonine cleavage (
[0259] Next, it was assessed whether it was also possible to omit threonine from the medium and rely on native threonine biosynthesis to provide this amino acid as a precursor for glycine and serine (
[0260] To confirm that, also in the absence of externally provided glycine or threonine, all cellular serine is produced from glycine condensation with formaldehyde, .sup.13C-labeling experiments were conducted. The strains were cultured in the presence of labeled or unlabeled methanol as well as glucose labeled at different carbons (glucose-1-.sup.13C, glucose-2-.sup.13C, and glucose-3-.sup.13C). While the labeling pattern of glycine changed according to the labeled carbon of glucose, cultivation with .sup.13C-methanol always resulted in exactly one more labeled carbon in serine than in glycine (
[0261] Overall, the obtained results confirm the capability of LtaE to convert threonine to serine in vivo by releasing acetaldehyde and assimilating formaldehyde. The findings further confirm the physiologically significant activity of half of the homoserine cycle, where homoserine metabolism to glycine and serine provided all the biomass requirement of these amino acids as well as cellular C.sub.1 moieties, together consisting 10% of the carbon in biomass (Neidhardt et al., in: Physiology of the Bacterial Cell: A Molecular Approach 134-143 (1990)).
Demonstration of the In Vivo Activity of Enzymes Catalyzing the Condensation of Glycine and Pyruvate to Form HOB and of the Conversion of HOB into Homoserine
[0262] After demonstrating methanol-dependent conversion of homoserine to serine, the aim was to demonstrate methanol-dependent conversion of pyruvate to homoserine. To select for the in vivo conversion of pyruvate to homoserine and threonine via HOB production and amination, a homoserine auxotroph strain was constructed: a deletion of the gene coding for aspartate-semialdehyde dehydrogenase (Δasd) resulted in a strain capable of growing only when homoserine and diaminopimelate (DAP) (Cardineau and Curtiss, J. Biol. Chem. 262 (1987), 3344-3353) were added to the medium. In this strain, homoserine is metabolized to methionine, threonine, and isoleucine, while DAP is metabolized to lysine and peptidoglycans. (It is noted that despite being formally reversible, homoserine dehydrogenase was not able to oxidize homoserine to aspartate-semialdehyde, the precursor of DAP, and hence the addition of the latter intermediate to the medium was required).
[0263] It was reasoned that, in the presence of methanol and methanol dehydrogenase, the combined activities of an enzyme catalyzing the formation of HOB by condensing pyruvate with formaldehyde and of an enzyme catalyzing the conversion of HOB into homoserine should enable the Δasd ΔfrmRAB strain to grow without the addition of homoserine to the medium (
[0264] It was found that overexpression of mdh together with rhmA, garL, yagE, or yjhH enabled growth of the Δasd ΔfrmRAB strain when homoserine was replaced with methanol (
[0265] As the reaction converting HOB into homoserine is known to be supported by the native aspartate aminotransferase (AspC), a highly expressed protein (Li et al., Cell 157 (2014), 624-635), and might be further catalyzed by other highly expressed, promiscuous aminotransferases, it was hypothesized that no dedicated enzyme overexpression would be required to enable this key reaction and this was indeed the case. In particular, growth was possible without dedicated overexpression of an aminotransferase enzyme. Genomic overexpression of aspC or of a mutated version of alanine aminotransferase (alaC*, the protein product of which was previously shown to catalyze the reaction in which homoserine is formed from HOB; Bouzon et al., ACS Synthetic Biology 6 (2017), 1520-1533) did not alter growth substantially (
[0266] To confirm that homoserine, and its downstream products threonine and methionine are produced from pyruvate and methanol via the reactions in which HOB is formed by the condensation of pyruvate with formaldehyde and the subsequent conversion of HOB into homoserine, .sup.13C-labeling experiments we performed. Upon cultivation with unlabeled glucose and .sup.13C-methanol, threonine and methionine were found to be completely once labeled, where lysine and aspartate (serving as control) were fully unlabeled. This confirms that homoserine and threonine are completely derived from pyruvate and methanol.